<DOC>
	<DOCNO>NCT01478256</DOCNO>
	<brief_summary>This study look improvement sign symptom patient inflammation lid , blepharitis , use two different FDA approve topical antibiotic agent , Besifloxocin Erythromycin . It also evaluate bacterial culture patient microbiologic evidence improvement .</brief_summary>
	<brief_title>Comparative Study Efficacy Topical Besifloxocin With Erythromycin Management Acute Blepharitis</brief_title>
	<detailed_description>This pilot project involve thirty patient specific form inflammtion lid call anterior blepharitis . The patient grade sign symptom randomize receive either topical Besifloxocin Erythromycin addition standard lid hygiene measure . All patient culture eyelid perform prior initiating therapy follow four week . The antibiotic use two week follow repeat culture lid obtain . The patient follow one additional week ensure recurrence symptom antibiotic discontinue . Only adult patient ( age 18-100 ) woman child bear potential include study . Then patient symptoms sign disease , blepharitis . Patient unstable antibiotic steroid regimen discontinue contact lens use include study .</detailed_description>
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<criteria>Acute blepharitis , age 18100 , Signs symptoms blepharitis woman child bear potential , eye surgery within three month study , contact lens wear , use topical antibacterial agent past two week , use topical oral steroid past two week unless stable dosage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>blepharitis</keyword>
	<keyword>topical erythromycin</keyword>
	<keyword>topical besifloxocin</keyword>
</DOC>